These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21969017)

  • 1. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
    Reynolds MR; Magnuson EA; Wang K; Thourani VH; Williams M; Zajarias A; Rihal CS; Brown DL; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Aug; 60(6):548-58. PubMed ID: 22818074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
    Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
    Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
    Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
    Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis.
    Arnold SV; Chinnakondepalli KM; Magnuson EA; Reardon MJ; Deeb GM; Gleason T; Yakubov SJ; Cohen DJ;
    JAMA Cardiol; 2021 Jan; 6(1):97-101. PubMed ID: 32997095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis.
    Arnold SV; Spertus JA; Lei Y; Allen KB; Chhatriwalla AK; Leon MB; Smith CR; Reynolds MR; Webb JG; Svensson LG; Cohen DJ
    Circ Heart Fail; 2013 Jan; 6(1):61-7. PubMed ID: 23230306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Baron SJ; Magnuson EA; Lu M; Wang K; Chinnakondepalli K; Mack M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Babaliaros V; Williams MR; Kereiakes D; Zajarias A; Alu MC; Webb JG; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2019 Dec; 74(23):2833-2842. PubMed ID: 31577923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.
    Svensson LG; Blackstone EH; Rajeswaran J; Brozzi N; Leon MB; Smith CR; Mack M; Miller DC; Moses JW; Tuzcu EM; Webb JG; Kapadia S; Fontana GP; Makkar RR; Brown DL; Block PC; Guyton RA; Thourani VH; Pichard AD; Bavaria JE; Herrmann HC; Williams MR; Babaliaros V; Généreux P; Akin JJ;
    J Am Coll Cardiol; 2014 Jul; 64(2):158-68. PubMed ID: 25011720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis.
    Humphries KH; Toggweiler S; Rodés-Cabau J; Nombela-Franco L; Dumont E; Wood DA; Willson AB; Binder RK; Freeman M; Lee MK; Gao M; Izadnegahdar M; Ye J; Cheung A; Webb JG
    J Am Coll Cardiol; 2012 Sep; 60(10):882-6. PubMed ID: 22818068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.